Topic Editors

Dr. Tomer Ziv-Baran
School of Public Health, Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv 6997801, Israel
1. The Davidai Arrhythmia Center, Leviev Heart Center, Sheba Medical Center, Ramat Gan 5265601, Israel
2. School of Medicine, Gray Faculty of Medical and Health Sciences, Tel-Aviv University, Tel Aviv 6997801, Israel

Epidemiology of Atrial Fibrillation: Trends, Insights, and Global Challenges

Abstract submission deadline
28 February 2027
Manuscript submission deadline
30 April 2027
Viewed by
1302

Topic Information

Dear Colleagues,

Atrial fibrillation (AF) affects over 60 million individuals worldwide and is associated with a significantly increased risk of stroke, heart failure, and all-cause mortality. With the global aging of the population, both the prevalence and healthcare burden of AF are steadily increasing, underscoring the urgent need for optimized strategies for its prevention, early detection, and management. Historically, AF diagnosis was reliant on documentation via standard 12-lead electrocardiography (ECG). However, the diagnostic landscape has evolved with the advent of continuous rhythm monitoring technologies, including wearable devices employing optical sensors and artificial intelligence-based algorithms. These innovations facilitate earlier detection and the timely initiation of therapy, particularly anticoagulation, to mitigate thromboembolic risk. Contemporary AF management has shifted toward an integrated, patient-centered model. Multidisciplinary care teams address modifiable risk factors and comorbidities while tailoring treatment strategies, which include rate and rhythm control through pharmacological therapy, electrical cardioversion, and catheter ablation. The recent introduction of pulsed field ablation (PFA), a novel non-thermal energy modality, offers enhanced procedural safety and efficiency and may represent a paradigm shift in interventional therapy. This Special Topic examines the global impact of AF and reviews emerging innovations in diagnostics, pharmacotherapy, and individualized care models aimed at improving clinical outcomes and reducing stroke incidence.

Dr. Tomer Ziv-Baran
Dr. Moshe Katz
Topic Editors

Keywords

  • atrial fibrillation
  • ablation
  • treatments
  • epidemiology
  • stroke
  • disease burden

Participating Journals

Journal Name Impact Factor CiteScore Launched Year First Decision (median) APC
Hearts
hearts
- - 2020 19 Days CHF 1000 Submit
Journal of Cardiovascular Development and Disease
jcdd
2.3 3.7 2014 28.8 Days CHF 2700 Submit
Journal of Clinical Medicine
jcm
2.9 5.2 2012 17.7 Days CHF 2600 Submit

Preprints.org is a multidisciplinary platform offering a preprint service designed to facilitate the early sharing of your research. It supports and empowers your research journey from the very beginning.

MDPI Topics is collaborating with Preprints.org and has established a direct connection between MDPI journals and the platform. Authors are encouraged to take advantage of this opportunity by posting their preprints at Preprints.org prior to publication:

  1. Share your research immediately: disseminate your ideas prior to publication and establish priority for your work.
  2. Safeguard your intellectual contribution: Protect your ideas with a time-stamped preprint that serves as proof of your research timeline.
  3. Boost visibility and impact: Increase the reach and influence of your research by making it accessible to a global audience.
  4. Gain early feedback: Receive valuable input and insights from peers before submitting to a journal.
  5. Ensure broad indexing: Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.

Published Papers (1 paper)

Order results
Result details
Journals
Select all
Export citation of selected articles as:
13 pages, 1720 KB  
Article
Long-Term Clinical Outcomes of Left Atrial Appendage Closure in Patients with Left Atrial Appendage Thrombus
by Moshe Katz, Rotem Nahmias Oz, Eias Massalha, Avi Sabag, Eyal Nof, Israel Barbash, Paul Fefer, Victor Guetta and Roy Beinart
J. Clin. Med. 2025, 14(21), 7589; https://doi.org/10.3390/jcm14217589 - 26 Oct 2025
Viewed by 825
Abstract
Background: Patients with atrial fibrillation (AF) who have a high bleeding risk or contraindications to anticoagulation may be candidates for left atrial appendage closure (LAAC). However, the presence of a thrombus in the left atrial appendage (LAA) is generally considered a contraindication [...] Read more.
Background: Patients with atrial fibrillation (AF) who have a high bleeding risk or contraindications to anticoagulation may be candidates for left atrial appendage closure (LAAC). However, the presence of a thrombus in the left atrial appendage (LAA) is generally considered a contraindication to the procedure. While the feasibility and short-term safety of LAAC in patients with pre-existing LAA thrombus has been reported, data on long-term outcomes remain limited. Objective: To assess the long-term clinical outcomes of AF patients undergoing LAAC in the presence of an LAA thrombus. Methods: This retrospective, single-center registry included all AF patients who underwent LAAC between June 2010 and April 2024. Patients were stratified based on the presence or absence of LAA thrombus at the time of the procedure. The primary endpoint was a 5-year composite of stroke, systemic embolism, or all-cause mortality. Results: A total of 403 patients underwent LAAC, of whom 24 (6%) had an LAA thrombus at the time of the procedure. During a median follow-up of 3.9 years, the primary endpoint occurred in 116 patients: 110 events (41%) in the no-thrombus group and 6 events (38%) in the thrombus group. There was no statistically significant difference in major adverse cardiovascular events (MACE) between groups (log-rank p = 0.862). Conclusions: LAAC may be performed safely in selected patients with distal LAA thrombus, with long-term outcomes comparable to those without thrombus. Full article
Show Figures

Figure 1

Back to TopTop